*Mechanisms of circular RNA in drug resistance of lung cancer: therapeutic targets, biomarkers, and future research directions
Abstract Lung cancer is one of the most prevalent malignant tumors globally, posing significant challenges to treatment outcomes. Circular RNAs (circRNAs), a novel class of non-coding RNAs, have emerged as crucial regulators in cancer biology, influencing drug resistance, progression, and prognosis....
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-05-01
|
| Series: | Discover Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s12672-025-02713-x |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850125452398559232 |
|---|---|
| author | Xuanlin Tao Xixian Ke Gang Xu |
| author_facet | Xuanlin Tao Xixian Ke Gang Xu |
| author_sort | Xuanlin Tao |
| collection | DOAJ |
| description | Abstract Lung cancer is one of the most prevalent malignant tumors globally, posing significant challenges to treatment outcomes. Circular RNAs (circRNAs), a novel class of non-coding RNAs, have emerged as crucial regulators in cancer biology, influencing drug resistance, progression, and prognosis. Due to their closed-loop structure, circRNAs demonstrate high stability and resistance to degradation, making them promising diagnostic and therapeutic targets. Here we summarize the mechanisms by which circRNAs mediate drug resistance in lung cancer, focusing on their roles in chemotherapy, targeted therapies, and immunotherapy. We highlight how circRNAs interact with microRNAs (miRNAs) and proteins to regulate signaling pathways and alter drug sensitivity. Additionally, circRNA expression patterns hold potential as biomarkers for predicting treatment response. By synthesizing the latest research, we offer new insights into circRNA functions and suggest future directions for overcoming drug resistance in lung cancer. Graphical Abstract |
| format | Article |
| id | doaj-art-2a7cfd5f1001414c84011bcbd7dce290 |
| institution | OA Journals |
| issn | 2730-6011 |
| language | English |
| publishDate | 2025-05-01 |
| publisher | Springer |
| record_format | Article |
| series | Discover Oncology |
| spelling | doaj-art-2a7cfd5f1001414c84011bcbd7dce2902025-08-20T02:34:07ZengSpringerDiscover Oncology2730-60112025-05-0116111310.1007/s12672-025-02713-x*Mechanisms of circular RNA in drug resistance of lung cancer: therapeutic targets, biomarkers, and future research directionsXuanlin Tao0Xixian Ke1Gang Xu2Department of Thoracic Surgery, Affiliated Hospital of Zunyi Medical UniversityDepartment of Thoracic Surgery, Affiliated Hospital of Zunyi Medical UniversityDepartment of Thoracic Surgery, Affiliated Hospital of Zunyi Medical UniversityAbstract Lung cancer is one of the most prevalent malignant tumors globally, posing significant challenges to treatment outcomes. Circular RNAs (circRNAs), a novel class of non-coding RNAs, have emerged as crucial regulators in cancer biology, influencing drug resistance, progression, and prognosis. Due to their closed-loop structure, circRNAs demonstrate high stability and resistance to degradation, making them promising diagnostic and therapeutic targets. Here we summarize the mechanisms by which circRNAs mediate drug resistance in lung cancer, focusing on their roles in chemotherapy, targeted therapies, and immunotherapy. We highlight how circRNAs interact with microRNAs (miRNAs) and proteins to regulate signaling pathways and alter drug sensitivity. Additionally, circRNA expression patterns hold potential as biomarkers for predicting treatment response. By synthesizing the latest research, we offer new insights into circRNA functions and suggest future directions for overcoming drug resistance in lung cancer. Graphical Abstracthttps://doi.org/10.1007/s12672-025-02713-xCircRNALung cancerDrug resistanceChemotherapyTargeted therapyBiomarkers |
| spellingShingle | Xuanlin Tao Xixian Ke Gang Xu *Mechanisms of circular RNA in drug resistance of lung cancer: therapeutic targets, biomarkers, and future research directions Discover Oncology CircRNA Lung cancer Drug resistance Chemotherapy Targeted therapy Biomarkers |
| title | *Mechanisms of circular RNA in drug resistance of lung cancer: therapeutic targets, biomarkers, and future research directions |
| title_full | *Mechanisms of circular RNA in drug resistance of lung cancer: therapeutic targets, biomarkers, and future research directions |
| title_fullStr | *Mechanisms of circular RNA in drug resistance of lung cancer: therapeutic targets, biomarkers, and future research directions |
| title_full_unstemmed | *Mechanisms of circular RNA in drug resistance of lung cancer: therapeutic targets, biomarkers, and future research directions |
| title_short | *Mechanisms of circular RNA in drug resistance of lung cancer: therapeutic targets, biomarkers, and future research directions |
| title_sort | mechanisms of circular rna in drug resistance of lung cancer therapeutic targets biomarkers and future research directions |
| topic | CircRNA Lung cancer Drug resistance Chemotherapy Targeted therapy Biomarkers |
| url | https://doi.org/10.1007/s12672-025-02713-x |
| work_keys_str_mv | AT xuanlintao mechanismsofcircularrnaindrugresistanceoflungcancertherapeutictargetsbiomarkersandfutureresearchdirections AT xixianke mechanismsofcircularrnaindrugresistanceoflungcancertherapeutictargetsbiomarkersandfutureresearchdirections AT gangxu mechanismsofcircularrnaindrugresistanceoflungcancertherapeutictargetsbiomarkersandfutureresearchdirections |